Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia

por Shukla, Vipul, Shukla, Ashima, Joshi, Shantaram S., Lu, Runqing
Publicado 2016

Experimental validation of predicted subcellular localizations of human proteins

por Chaturvedi, Nagendra K, Mir, Riyaz A, Band, Vimla, Joshi, Shantaram S, Guda, Chittibabu
Publicado 2014

IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia

por Pathak, Simanta, Ma, Shibin, Trinh, Long, Eudy, James, Wagner, Kay-Uwe, Joshi, Shantaram S., Lu, Runqing
Publicado 2011

Long non-coding RNA profiling of pediatric Medulloblastoma

por Kesherwani, Varun, Shukla, Mamta, Coulter, Don W., Sharp, J. Graham, Joshi, Shantaram S., Chaturvedi, Nagendra K.
Publicado 2020

Exosomes secreted under hypoxia enhance stemness in Ewing’s sarcoma through miR-210 delivery

por Kling, Matthew J., Chaturvedi, Nagendra K., Kesherwani, Varun, Coulter, Don W., McGuire, Timothy R., Sharp, J. Graham, Joshi, Shantaram S.
Publicado 2020

Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan

por Chaturvedi, Nagendra K., McGuire, Timothy R., Coulter, Don W., Shukla, Ashima, McIntyre, Erin M., Sharp, John Graham, Joshi, Shantaram S.
Publicado 2016

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia

por Mittal, Amit K., Chaturvedi, Nagendra K., Rohlfsen, Rae A., Gupta, Payal, Joshi, Avadhut D., Hegde, Ganapati V., Bociek, R. Gregory, Joshi, Shantaram S.
Publicado 2013

Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy

por Chaturvedi, Nagendra K., Kling, Matthew J., Coulter, Don W., McGuire, Timothy R., Ray, Sutapa, Kesherwani, Varun, Joshi, Shantaram S., Sharp, J. Graham
Publicado 2018

Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice

por Haney, Staci L., Upchurch, Garland M., Opavska, Jana, Klinkebiel, David, Appiah, Adams Kusi, Smith, Lynette M., Heavican, Tayla B., Iqbal, Javeed, Joshi, Shantaram, Opavsky, Rene
Publicado 2016

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma

por Kling, Matthew J., Griggs, Connor N., McIntyre, Erin M., Alexander, Gracey, Ray, Sutapa, Challagundla, Kishore B., Joshi, Shantaram S., Coulter, Don W., Chaturvedi, Nagendra K.
Publicado 2021

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma

por Kling, Matthew J., Kesherwani, Varun, Mishra, Nitish K., Alexander, Gracey, McIntyre, Erin M., Ray, Sutapa, Challagundla, Kishore B., Joshi, Shantaram S., Coulter, Don W., Chaturvedi, Nagendra K.
Publicado 2022

Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts

por Vellichirammal, Neetha Nanoth, Albahrani, Abrar, Banwait, Jasjit K., Mishra, Nitish K., Li, You, Roychoudhury, Shrabasti, Kling, Mathew J., Mirza, Sameer, Bhakat, Kishor K., Band, Vimla, Joshi, Shantaram S., Guda, Chittibabu
Publicado 2020

Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma

por Chaturvedi, Nagendra K., Mahapatra, Sidharth, Kesherwani, Varun, Kling, Matthew J., Shukla, Mamta, Ray, Sutapa, Kanchan, Ranjana, Perumal, Naveenkumar, McGuire, Timothy R., Sharp, J. Graham, Joshi, Shantaram S., Coulter, Don W.
Publicado 2019

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513

por Coulter, Don W., McGuire, Timothy R., Sharp, John G., McIntyre, Erin M., Dong, Yuxiang, Wang, Xiaofang, Gray, Shawn, Alexander, Gracey R., Chatuverdi, Nagendra K., Joshi, Shantaram S., Chen, Xiaoyu, Vennerstrom, Jonathan L.
Publicado 2016